Psychiatry Department Faculty

Andrea King, PhD
Phone:	773-702-6181
Email:	aking@yoda.bsd.uchicago.edu
Pager:	7567
Office:	A-310, L-470

Specialty: Addictions

About:

Dr. King received her B.S. in Psychology at the University of Illinois, Champaign-Urbana, IL in 1987. Her graduate studies were in Biopsychology at the University of Oklahoma Health Sciences Center, Oklahoma City, OK. She received her Ph.D. in 1992. After her doctoral work, Dr. King completed a 2-year Addiction Research Fellowship at the University of Pennsylvania, Philadelphia, PA, from 1992-1994. She also received respecialization training in clinical psychology at the University of Pennsylvania. Dr. King conducted her APA-approved Clinical Psychology Internship from 1994-1995 at the New York Medical College, St. Vincent's Hospital, New York, NY. She has been a Licensed Clinical Psychologist in the state of Illinois since 1997.

Research Interests:
Dr. King is Principal Investigator on several nationally-funded grants by the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse. Dr. King has grant support from The University of Chicago Brain Research Foundation. She has received grant funding support in the past from the Alcoholic Beverage Medical Research Foundation.

Specific Research Interests:

Individual risk factors for substance abuse and dependence
Subjective and physiological mechanisms underlying hazardous drinking
Examining efficacy of the opioid antagonist in smoking cessation treatment
Stress and the HPA axis involvement in the maintenance of addictions
Neurobiology of alcohol’s effects on cigarette craving
Sex differences in addictive behaviors and treatment outcome

Clinical Interests:
Dr. King provides supervision for clinical trainees in the Department of Psychiatry. She also provides direct supervision and oversight of all clinical activities in treatment studies conducted at CARL.

Specific Clinical Interests:

Treatment of co-morbid alcohol and nicotine dependence
Targeted and individualized treatments for substance abuse clients
Enhancing motivational and combination treatment modalities for optimal effectiveness in substance use disorders

Selected Publications

Epstein, A.M., Sher, T.G., Young, M.A., & King, A.C. (In press, 2006). Tobacco chippers show robust increases in smoking urge after alcohol consumption. Naltrexone attenuates acute cigarette smoking behavior. Psychopharmacology.

King, A.C., de Wit, H., Riley, R.C., Cao, D., Niaura, R., Hatsukami, D. (2006). Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine & Tobacco Research 8: 1-12.

King, A.C., Munisamy, G., de Wit, H., & Lin, S. (2006). Attenuated cortisol response to alcohol in heavy social drinkers. International Journal of Psychophysiology 59: 203-209.

King, A.C., & Epstein, A.M. (2005). Alcohol dose-dependent increases in smoking urge in light smokers. Alcoholism: Clinical and Experimental Research 29: 547-552.

Epstein, A.M. & King, A.C. (2004). Naltrexone attenuates acute cigarette smoking behavior. Pharmacology, Biochemistry, and Behavior 77: 29-37.

King, A.C. & Canada, S.A. (2004). Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. Journal of Substance Abuse Treatment 26: 189-195.

King, A.C. & Byars, J.A. (2004). Alcohol-induced performance impairment in heavy episodic and light social drinkers. Journal of Studies on Alcohol 65: 27-36.

Bernardy, N.C., King, A.C., & Lovallo, W.R. (2003). Cardiovascular responses to physical and psychological stress in female alcoholics with transitory hypertension after early abstinence. Alcoholism: Clinical and Experimental Research 27: 1489-1498.

King, A.C., Houle, T., de Wit, H., Holdstock, L., & Schuster, A. (2002). Biphasic alcohol response differs in heavy versus light drinkers. Alcoholism: Clinical and Experimental Research 26: 827-835.

King, A.C., & Meyer, P.J. (2000). Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacology, Biochemistry, and Behavior, 66, 563-572.